Reprint

Nutraceutical Approaches to Cardiovascular and Metabolic Diseases: Evidence and Opportunities

Edited by
March 2023
214 pages
  • ISBN978-3-0365-7130-0 (Hardback)
  • ISBN978-3-0365-7131-7 (PDF)

This book is a reprint of the Special Issue Nutraceutical Approaches to Cardiovascular and Metabolic Diseases: Evidence and Opportunities that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

A major task for health professionals and health systems is effectively preventing and treating cardiovascular and metabolic diseases. This reprint offers an updated set of experimental and clinical information on the usefulness of nutraceutical products for the management of cardiometabolic diseases, which range from obesity and diabetes mellitus and their complications to hypercholesterolemia. The nutraceutical option may be used according the “beyond diet, before drug” strategy and is particularly relevant in the cardiometabolic field. The chapters of this reprint offer a deep insight into relevant issues in this nutraceutical field, such as experimental research for the preclinical identification of interesting compounds of natural origin, quality of nutraceutical products and their efficacy and safety, regulatory aspects, and the quality of evidence-based medicine.

Format
  • Hardback
License
© by the authors
Keywords
Atherosclerotic Cardiovascular Diseases; Gut Microbiota; next generation sequencing; oxysterols; 24-OHC; 25-OHC; 27-OHC; cholesterol metabolism; probiotic; cardiovascular risk; hypercholesterolemia; monacolin K; nutraceutical; very-low calorie ketogenic diet; obesity; cardiovascular risk; insulin resistance; nutraceutical; diabetic retinopathy; macular xanthophylls; carotenoids; macular pigment; macular pigment optical density; MPOD; lutein; zeaxanthin; meso-zeaxanthin; diabetes; diabetic retinopathy; retinal neurodegeneration; neuroprotection; phytosterols; plant sterols; cholesterol; cardiovascular disease; supplements; functional foods; PREDIMED; Mediterranean diet; lipid profile; cardiovascular risk; polyphenols; menopause; body fat; biomarkers; tartaric acid; nutraceuticals; dyslipidaemia; atherosclerosis; tree nuts; peanuts; fatty acids; prospective studies; randomized clinical trials; cardiovascular risk; type-2 diabetes; cancer; hypertension; cognitive function; mortality; body weight; blood lipids; inflammation; PREDIMED; dietary lipids; immune-inflammation; cardiovascular disease; microbiota; Cameroonian spice extracts; SW 872 adipocytes; triglyceride accumulation; glucose uptake; oxidative stress; pro-inflammatory cytokines; Prunus domestica L.; chemical characterization; digestive enzyme inhibition; HMG-CoA reductase inhibition; anti-inflammatory activity; guidelines; nutraceutical product; cardiovascular disease; dyslipidaemia; metabolic disease; type 2 diabetes mellitus; n/a